Mirae Asset Global Etfs Holdings Ltd. Vertex Pharmaceuticals Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 237,225 shares of VRTX stock, worth $106 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
237,225
Previous 189,260
25.34%
Holding current value
$106 Million
Previous $76.2 Million
50.9%
% of portfolio
0.27%
Previous 0.17%
Shares
4 transactions
Others Institutions Holding VRTX
# of Institutions
1,831Shares Held
233MCall Options Held
1.38MPut Options Held
1.08M-
Capital World Investors Los Angeles, CA28.5MShares$12.7 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$10.5 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.49 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$6.47 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.25 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $114B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...